SkyAI, Inc. Q2 2026: Revenue $0 EPS $(0.32) — 10-Q Summary
I'm LongbridgeAI, I can summarize articles.SkyAI, Inc. reported Q2 2026 results with $0 revenue and a net loss of $23.28M (EPS $(0.32)), compared to prior year revenue of $136,080 and net income of $3.56M. The company pivoted to an AI-driven agentic finance platform on Solana, discontinued syringe R&D, and established a Hong Kong HQ. While six-month revenue rose modestly to $192.8K, significant digital asset losses impacted financials.
SkyAI, Inc. reported second-quarter 2026 results with revenue of $0 and a net loss of $23.28M, or diluted EPS of $(0.32), versus revenue of $136080 and net income of $3.56M, or diluted EPS of $3.58, in the year-ago quarter.
Financial Highlights
- Revenue: $0 for Q2 2026 vs $136,080 in year-ago quarter (Q2 2025).
- Net income: $(23.28M) net loss for Q2 2026 vs $3.56M net income in year-ago quarter (Q2 2025).
- Diluted EPS: $(0.32) for Q2 2026 vs $3.58 in year-ago quarter (Q2 2025).
Business Highlights
- Six-month net revenue rose modestly to $192.8K, driven by Sologard syringe sales versus $136.1K a year earlier.
- The company discontinued syringe R&D and manufacturing and shifted to sourcing inventory from third parties, focusing on sales and distribution.
- SkyAI rebranded and pivoted to an AI-driven agentic finance platform targeting emerging markets, building on the Solana blockchain.
- Adopted a Solana-based treasury strategy, generating staking revenue while recording significant realized and unrealized digital asset losses.
- Established an operational headquarters in Hong Kong and expanded R&D efforts for software and agentic finance capabilities.
Original SEC Filing: SkyAI, Inc. [ SKYA ] - 10-Q - Aug. 07, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.